Recent Updates
Recently added Catalysts
SRXH Positive Sentiment Score: 75/100

SRx Health Solutions Redeems Series A Preferred Stock and Cancels Approximately 125,000,000 Shares of Common Stock, Improving Balance Sheet Flexibility for Investment in M&A or Return of Capital to

Key Takeaway: SRx Health Solutions, Inc. has redeemed 17,500 shares of its Series A Preferred Stock, which corresponds to the cancellation of approximately 125,000,000 shares of common stock. This action is intended to enhance the flexibility of the company's balance sheet for future investments or the return of capital to shareholders. Although there are no immediate plans for mergers and acquisitions (M&A), the company will continue to evaluate opportunities as they arise. The firm expects to file its Form 10-Q with the SEC soon.

Market Sentiment Analysis

POSITIVE FACTORS

  • Redemption of preferred stock improves balance sheet flexibility.
  • Cancellation of shares enhances capital structure for future growth.
  • Potential for future investments in M&A is implied.

Full Press Release Details

Health Solutions Redeems Series A Preferred Stock and Cancels Approximately 125,000,000 Shares of Common Stock, Improving Balance Sheet
Flexibility for Investment in M&A or Return of Capital to Shareholders
PALM BEACH, FL - February 11, 2026 - SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") today
announced that it has redeemed 17,500 shares of its Series A Preferred Stock pursuant to the terms of the Series A Preferred Stock, representing
approximately 125,000,000 shares of common stock on an as-converted basis. On October 31, 2025 the Company issued and sold in a private
placement 19,035 shares of the Series A Preferred Stock for aggregate proceeds of approximately $15.23 million.
Company expects to file its Form 10-Q with the SEC for its fiscal first quarter for the period ended December 31, 2025 on Friday, February
Young, Board Member of SRx Health, commented, "The retirement of the preferred and cancellation of approximately 125,000,000 shares
of common stock allows for further flexibility of our capital structure for additional investments in the future."
does not have immediate plans for M&A as of the date of this release that has not been already disclosed, but will continue to evaluate
opportunities from time to time.
press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such
as "believe," "expect," "intend," "aim," "plan," "may," "could,"
"target," and similar expressions are intended to identify forward-looking statements. These statements are based on current
expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those
expressed or implied. These risks include, but are not limited to, the ability to complete the proposed transaction, shareholder approvals,
market conditions, regulatory considerations, and other risks described in the Company's filings with the Securities and Exchange
Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except
Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer
Strategic Communications
Valter Pinto, Managing Director
Strategic Communications
Kristin Cwalinski, Senior Vice President

Frequently Asked Questions

What recent financial move did SRx Health Solutions make?

SRx Health Solutions redeemed 17,500 shares of Series A Preferred Stock.

How many shares of common stock were canceled?

Approximately 125,000,000 shares of common stock were canceled.

What is the reason for redeeming the preferred stock?

The redemption provides flexibility for future investments or shareholder returns.

Is the company planning any M&A activities?

Currently, there are no immediate plans for M&A, but opportunities will be evaluated.

When will SRx Health file its Form 10-Q?

The Form 10-Q will be filed with the SEC on February 11, 2026.

Last updated: Feb 11, 2026